These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 30540704)
1. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Davidovics ZH; Michail S; Nicholson MR; Kociolek LK; Pai N; Hansen R; Schwerd T; Maspons A; Shamir R; Szajewska H; Thapar N; de Meij T; Mosca A; Vandenplas Y; Kahn SA; Kellermayer R; J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):130-143. PubMed ID: 30540704 [TBL] [Abstract][Full Text] [Related]
2. Addendum for: Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr; 2020 Mar; 70(3):404. PubMed ID: 31880660 [No Abstract] [Full Text] [Related]
3. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile). Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495 [TBL] [Abstract][Full Text] [Related]
4. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. Song Y; Garg S; Girotra M; Maddox C; von Rosenvinge EC; Dutta A; Dutta S; Fricke WF PLoS One; 2013; 8(11):e81330. PubMed ID: 24303043 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease. Tariq R; Disbrow MB; Dibaise JK; Orenstein R; Saha S; Solanky D; Loftus EV; Pardi DS; Khanna S Inflamm Bowel Dis; 2020 Aug; 26(9):1415-1420. PubMed ID: 31821444 [TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes. Girotra M; Garg S; Anand R; Song Y; Dutta SK Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476 [TBL] [Abstract][Full Text] [Related]
7. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Mullish BH; Merrick B; Quraishi MN; Bak A; Green CA; Moore DJ; Porter RJ; Elumogo NT; Segal JP; Sharma N; Marsh B; Kontkowski G; Manzoor SE; Hart AL; Settle C; Keller JJ; Hawkey P; Iqbal TH; Goldenberg SD; Williams HRT J Hosp Infect; 2024 Jun; 148():189-219. PubMed ID: 38609760 [TBL] [Abstract][Full Text] [Related]
8. The use of faecal microbiota transplant as treatment for recurrent or refractory Mullish BH; Merrick B; Quraishi MN; Bak A; Green CA; Moore DJ; Porter RJ; Elumogo NT; Segal JP; Sharma N; Marsh B; Kontkowski G; Manzoor SE; Hart AL; Settle C; Keller JJ; Hawkey P; Iqbal TH; Goldenberg SD; Williams HRT Gut; 2024 Jun; 73(7):1052-1075. PubMed ID: 38609165 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection. Varier RU; Biltaji E; Smith KJ; Roberts MS; Kyle Jensen M; LaFleur J; Nelson RE Infect Control Hosp Epidemiol; 2015 Apr; 36(4):438-44. PubMed ID: 25782899 [TBL] [Abstract][Full Text] [Related]